‘Upsilon’ is the 20th letter of the Greek alphabet. It is known as Pythagoras’ letter, so called because its forked shape was seen to symbolise moral choice.
‘Upsilon Global’ is a clinical research partnership that specialises in supporting CROs, Biotechs, Pharmaceuticals and Medical Device companies who have made the right choice for assistance with their clinical studies.
“In an industry where each clinical trial is unique, why don’t outsourcing providers tailor every service to optimise project outcomes on an individual basis?”
“Why do so many service providers still think that a one-size-fits-all approach is relevant in today’s world?”
Upsilon Global was founded on the basis that adaptability and flexibility are the most important attributes when working with small/medium sized organisations in the clinical space. We aim to accelerate your clinical trials using a quality-focused, cost and time efficient model, without jeopardising the integrity of your study.
As a strategic partner, we tailor a solution offering you one of our hand-picked specialists based on the specific requirements of your study. We provide entire clinical study teams or individual skilled resources, and provide you with regional experts who speak the local language, understand the native regulatory and ethics processes and, perhaps most importantly, have existing relationships with local KOLs, sites and PIs.
Our partnership service is designed to optimise and streamline current and future clinical development programs through our extended global network of specialist therapeutic experts.
We understand the inherent challenges that small companies face, as well as the importance of having a trusted partner to support your requests and offer continued advice and support, particularly in countries and regions that may be new to your organisation.